As the global pharmaceutical market is expected to reach over $1.5T by the end of 2023, life sciences is entering a new era of cutting-edge technology, top-of-the-line research, and breakthrough treatments.
A new report by Newsweek highlights life sciences leaders and CEOs across America to discuss medicine, progress in the industry, regulatory challenges and the intersection of technology and healthcare.
“Looking ahead, I think we will see dramatic changes in cancer survival rates. It is inspiring to witness that we already have the tools to develop the next generation of therapies, but we need to bring costs down as personalized cancer treatments are often very expensive,” said Life Science Washington’s CEO and President Marc Cummings.